BOTALYS

Ghislenghien, Belgium

We seek wild precision for the Nutraceutical industry by developing pristine bioactive botanicals, using indoor farming.

$3.4M raised

Nov 2025

Convertible Note

Top Investors

The Yield Lab EuropeVives Louvain Technology FundTeseo CapitalHorizon 2020S.R.I.W.

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BOTALYS raised?

BOTALYS has raised $3.4M in total funding. The most recent round was Convertible Note. The last funding was announced in November 2025.

Who are BOTALYS's investors?

BOTALYS's investors include The Yield Lab Europe, Vives Louvain Technology Fund, Teseo Capital, Horizon 2020, S.R.I.W..

Where is BOTALYS headquartered?

BOTALYS is headquartered in Ghislenghien, Belgium.

What does BOTALYS do?

We seek wild precision for the Nutraceutical industry by developing pristine bioactive botanicals, using indoor farming.

What stage is BOTALYS at?

BOTALYS is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 21, 2025.

MLA

"BOTALYS — Funding & Investors." VCBacked, November 21, 2025, https://www.vcbacked.co/company/botalys. Accessed June 16, 2026.

APA

VCBacked. (2025). BOTALYS — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/botalys

Wikipedia (cite web)

{{cite web |title=BOTALYS — Funding & Investors |url=https://www.vcbacked.co/company/botalys |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 21, 2025.